Stinchcombe, T., Zhang, Y. J., Vokes, E. E., Schiller, J. H., Bradley, J. D., Curran, W. J., … Wang, X. F. (2016). A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts). In Journal of Clinical Oncology (Vol. 34, pp. 8508–8508). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.8508

Stinchcombe, Tom, Ying J. Zhang, Everett E. Vokes, Joan H. Schiller, Jeffrey D. Bradley, Walter John Curran, Benjamin Movsas, et al. “A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts).” In Journal of Clinical Oncology, 34:8508–8508. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.8508.

Stinchcombe T, Zhang YJ, Vokes EE, Schiller JH, Bradley JD, Curran WJ, et al. A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8508–8508.

Stinchcombe, Tom, et al. “A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts).” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 8508–8508. Crossref, doi:10.1200/jco.2016.34.15_suppl.8508.

Stinchcombe T, Zhang YJ, Vokes EE, Schiller JH, Bradley JD, Curran WJ, Movsas B, Schild SE, Clamon GH, Govindan R, Blumenschein GR, Socinski MA, Ready N, Akerley WL, Cohen HJ, Pang H, Wang XF. A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8508–8508.